Glenmark Pharmaceuticals Limited (BOM:532296)
2,031.80
-25.25 (-1.23%)
At close: Aug 13, 2025
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 14,989 employees as of March 31, 2024. The number of employees decreased by 567 or -3.64% compared to the previous year.
Employees
14,989
Change (1Y)
-567
Growth (1Y)
-3.64%
Revenue / Employee
8.96M INR
Profits / Employee
698.58K INR
Market Cap
572.67B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 403,303 |
HDFC Bank | 214,521 |
Bharti Airtel | 13,593 |
Tata Consultancy Services | 607,979 |
ICICI Bank | 182,665 |
State Bank of India | 236,226 |
Infosys | 323,578 |
Hindustan Unilever | 18,802 |
Glenmark Pharmaceuticals News
- 4 weeks ago - Nomura remains neutral on Glenmark, says near-term upside for stock captured post ISB-2001 deal - Business Upturn
- 4 weeks ago - Top stocks to buy: Stock recommendations for the week starting July 14, 2025 - check list - The Times of India
- 4 weeks ago - Top stocks in focus on July 14; DMart, Glenmark Pharma, VIP Industries, NCC, RITES, Ajmera Realty and more - Business Upturn
- 4 weeks ago - HSBC raises Glenmark Pharma share price target to Rs 2,275 on $1.9 billion AbbVie licensing deal - Business Upturn
- 4 weeks ago - Glenmark Pharma receives warning letter from US FDA for Indore facility - Business Upturn
- 4 weeks ago - Glenmark Pharma shares surge 10% after its subsidiary signs $700 million licensing deal with AbbVie for ISB 2001 - Business Upturn
- 4 weeks ago - Top stocks in focus on July 11: Tata Steel, TCS, Tata Elxsi, Glenmark Pharma, HUL, JSW Infrastructure and more - Business Upturn
- 4 weeks ago - Glenmark shares in focus after $700 million AbbVie deal for ISB 2001 - Business Upturn